Stefano Nava
Overview
Explore the profile of Stefano Nava including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
260
Citations
5738
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reyes L, Torres A, Olivella-Gomez J, Ibanez-Prada E, Nseir S, Ranzani O, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001371
: Nosocomial lower respiratory tract infections (nLRTIs) are associated with unfavorable clinical outcomes and significant healthcare costs. nLRTIs include hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and other ICU-acquired pneumonia phenotypes....
2.
Optimising non-invasive ventilation in acute COPD exacerbations: Beyond pressure and volume settings
Crimi C, Carlucci A, Nava S
Pulmonology
. 2025 Feb;
31(1):2448080.
PMID: 39981735
No abstract available.
3.
Pisani L, Vega M, Ageno E, Prediletto I, Dongilli R, Catalanotti V, et al.
Pulmonology
. 2025 Jan;
31(1):2411813.
PMID: 39883488
Nasal high flow (NHF) therapy is an established form of non invasive respiratory support used in acute and chronic care. Recently, a new high flow nasal cannula with asymmetric prongs...
4.
Ursoleo J, Bottussi A, Sullivan D, DAndria C, Smirnova N, Rosa W, et al.
Eur J Intern Med
. 2025 Jan;
133:25-34.
PMID: 39794226
Chronic obstructive pulmonary disease (COPD) is a life-limiting condition and the third leading cause of death worldwide. People with COPD experience physical and psychological symptoms and functional limitations that impair...
5.
[Contemporary diagnosis and treatment of tricuspid regurgitation: from neglected valve to primetime]
Montalto C, Tognola C, Ghidini S, Monticelli M, Nava S, Soriano F, et al.
G Ital Cardiol (Rome)
. 2024 Jul;
25(8):576-589.
PMID: 39072596
Tricuspid insufficiency has long been considered an entity with low prognostic importance and associated with symptoms and signs only secondarily to left heart pathology. Scientific research in recent years has...
6.
Cedirian S, Comellini V, Chessa M, Ravaioli G, Misciali C, Nava S, et al.
Ital J Dermatol Venerol
. 2024 May;
159(3):344-348.
PMID: 38808460
Background: Sarcoidosis is a multisystemic granulomatous disease which not only affect the skin but can also involve the lymph nodes, eyes, and lungs. Subcutaneous sarcoidosis (SCS), is a rare form...
7.
Bassi I, Pastorello S, Guerrieri A, Giancotti G, Cuomo A, Rizzelli C, et al.
Eur J Intern Med
. 2024 May;
128:81-86.
PMID: 38789287
Background: Idiopathic Pulmonary Fibrosis (IPF) is a lethal disease; most patients die in hospitals because palliative care (PC) is not wildly and early available. We aimed to determine the impact...
8.
Soriano F, Munafo A, Baydaroglu N, Nava S, Bruschi G, Esposito G, et al.
Eur Heart J Case Rep
. 2024 May;
8(5):ytae237.
PMID: 38774771
Background: There is a growing need for percutaneous coronary intervention (PCI) to be performed within the same transcatheter aortic valve implantation (TAVI) procedure. In such cases, cangrelor, a fast-acting intravenous...
9.
Duggal A, Conrad S, Barrett N, Saad M, Cheema T, Pannu S, et al.
Am J Respir Crit Care Med
. 2024 Jan;
209(5):529-542.
PMID: 38261630
It is unclear whether extracorporeal CO removal (ECCOR) can reduce the rate of intubation or the total time on invasive mechanical ventilation (IMV) in adults experiencing an exacerbation of chronic...
10.
Veas N, Winter J, Soriano F, Valdebenito M, Piccaluga E, Nava S, et al.
Rev Med Chil
. 2023 Oct;
150(5):618-624.
PMID: 37906762
Background: Transcatheter Aortic Valve Implantation (TAVI) is beneficial in patients with symptomatic severe Aortic Stenosis (AS). There is no consensus about the best anticoagulation strategy for patients with a recent...